A test to gauge recurrence risk for kidney cancer is unable to predict which patients will benefit from adjuvant therapy
An American company called Genomic Health has been collaborating with [...]
16-gene recurrence score for high-risk kidney cancer offers prognostic value
Results from a phase III trial presented at the American [...]
Potential molecular scoring method for predicting survival in metastatic kidney cancer
A recent study presented at the American Urology Association (AUA) [...]
